The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial

EuroIntervention 2013;8:1047-1051. DOI: 10.4244/EIJV8I9A161

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Abbott Vascular, Diegem, Belgium

Aims: To assess the safety and performance of the XIENCE V everolimus-eluting stent (EES) versus the TAXUS paclitaxel-eluting stent (PES) in the treatment of patients with

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

Latest news